* Cardlytics Inc CDLX.OQ reported a quarterly adjusted
loss
of 50 cents per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of 57 cents per share.
* Revenue rose 11.9% to $72.71 million from a year ago;
analysts
expected $73.90 million.
* Cardlytics Inc's reported EPS for the quarter was 19
cents.
* The mean earnings estimate of analysts had fallen by
about 29.1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Cardlytics Inc shares had risen by 0.3% this quarter and
lost 85.7% so far this year.
* The company reported quarterly net income of $6.27
million.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$13.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
1 at 10:05 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.57 -0.50 Beat
Jun. 30 2022 -0.47 -0.65 Missed
Mar. 31 2022 -0.55 -0.38 Beat
Dec. 31 2021 -0.42 -0.15 Beat